The site will be unavailable from 11:00 PM GMT on Tuesday, 21 July 2026, until 4:00 AM GMT on Wednesday, 22 July 2026, due to scheduled maintenance.

elderly

20th May 2025

Health outcomes and healthcare service use in older adults with and without multiple sclerosis: a plain language summary

This summary describes an article published in the medical journal Frontiers in Oncology in September 2023. The article reports results from a study that looked at breast cancer treatments for older patients aged 75 years or older. The study focused on a type of cancer called HR+/HER2- metastatic breast cancer. HR+/HER2- stands for hormone receptor-positive/human epidermal growth factor receptor 2-negative. This study evaluated whether older patients with this type of cancer benefited from the combination of two medicines – palbociclib and an aromatase inhibitor – compared with taking an aromatase inhibitor alone.

30th Apr 2024

elderly

Health outcomes and healthcare service use in older adults with and without multiple sclerosis: a plain language summary

Palbociclib plus an aromatase inhibitor for older patients with metastatic breast cancer